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Abstract 
        Type 2 diabetes(TIIDM) aging-related disorder, is caused by a combination of peripheral insulin resistance and 
β-cell dysfunction .Recent evidence, however, suggests that TIIDM is additionally characterized by impaired β-cell 
regeneration and reduced β-cell mass .Shortened telomeres have been previously associated with diabetes in several 
small-scale studies(Zhu et al.,2011). Measurement of telomere length in diabetic patients in different age and 
different duration of disease and compared with control. Also included the comparison telomere length between male 
and female for both control and diabetic groups and  between patients from genetic origin (mother origin or father 
origin) and patients from non genetic origin  . Genomic DNA was prepared from whole blood extraction using 
genaid kit and was quantified by Nanodrop .Terminal restriction fragment (TRF) lengths were measured using the 
Southern-blotting technique .This study was conducted between November 2010- November 2012 and, it was carried 
out at the diabetic Centre / Merjan Teaching Hospital in Babel Province by taking 54 diabetic patients(Type II DM) 
with disease duration (0-5),(>5-10 )and (>10 )years ,with age average (35-65 year)and most of them were on oral 
hypoglycemic drugs. While the study included 18 people apparently healthy that included 9 male and 9 female with 
age average (35-65 year) .The study revealed that telomere length(TL) were differences between males and females 
of control group. Age- adjusted telomere length were shorter in males than in females of control subjects (13,200 bp 
) vs. (11,600 bp), (14,200 bp) vs. (13,000 bp) and (15,100 bp) vs. (13,800 bp) ,and this differences in TL between 
males and females decreased as aging increased, while this gender differences in TL was not observed among the 
diabetic patients .In both the controls group and diabetic subjects, the telomere length were shorter in older subjects 
than younger for both males and females. The result show differences in TL between control and diabetic subjects. 
TL were shorter in the patients with Type 2diabetes compared with the control subjects ,and TL in first duration of 
male diabetic patients(2,100 bp) in male(55 years) and (1,900 bp) in male (65 years) ,and second duration of female 
diabetic patients (3,600 bp) in female (55 years) and (2,900 bp) in female (65 years) were shorter compared with 
other duration. The differences in TL in patients with family history of disease shown shorter than patients without 
family history of disease and this differences in TL in patients with family history of disease from mother origin 
shorter than patients with family history of disease from father origin. 
The result of telomere length (TL) show that TL were shorter in males than females of control group while this 
differences absent in diabetic patients .TL was shorter in first duration of disease in males diabetic patients and in 
second duration of females diabetic patients compared with other duration of disease. TL was shorter in older 
subjects than younger for both groups and for both gender ,also shorter in diabetic patients from genetic origin of 
disease than non-genetic origin. Positive correlation between TL and estrogen in female control group and between  
TL and adiponectin in diabetic patients was found. 
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1. Introduction 
  Telomeres are specialized terminal elements composed of tandem repetitive sequences (TAAGGG)n and specific 
proteins .In many eukaryotes, telomeric repeat tracts are maintained by a telomere-specific reverse transcriptase , 
telomerase that can counteract the loss of terminal sequences during DNA replication (Griffith et al.,1999 ; Surzycki, 
2003).  Epel,(2009) ; Salpeaa et al.,(2010) and Salpea and Humphries (2010) speculate that critically short telomeres 
contribute to the onset of diabetes by eliciting senescent phenotypes in beta cells. Also Fernandez-Egea et al.,(2009) , 
Peng et al.,(2009) and Salpea et al., (2010) mentions that shortened telomere is associated with type 1 and type 2 
diabetes ,because abnormal oxidation/reduction balance has also been associated with diabetes .Oxidative stress 
accelerates aging, increases the amount of telomeric DNA lost during each replication cycle. 
       The classical perception of adipose tissue as a storage place of fatty acids has been replaced over the last years 
by the notion that adipocytes and adipose tissue produce a wide range of hormones and cytokines involved in 
glucose metabolism including adiponectin (Hajer et al.,2008 ; Díez and Iglesias, 2009). Adiponectin was first 
identified in 1995, also termed Acrp30, AdipoQ ,apM1,or GBP28 , was originally identified independently by 
4groups using different approaches . Circulates at relatively high concentration of 2 to 30 µg/ml in blood, 
accounting for up to 0.01% of total plasma protein in humans  (Daimon et al.,2003;Shimada et al.,2004; Kadowaki et 
al.,2006 and  Heidemann et al.,2008). Adiponectin encoded by gene APM1 which has been mapped to chromosome 
3 q 27 ,consist from 244 amino acid, abundantly synthesized and secreted by the adipose tissue, has structural 
homology to complement factor C1q and collagen VIII and X (Nedvidkova et al.,2005).    Adiponectin exists in 3 
major oligomeric forms:alow–molecular weight (LMW) ,trimer a middle - molecular weight(MMW), hexamer 
and high-molecular weight (HMW) 12-18-mer adiponectin.Several observations support the hypothesis that 
HMW adiponectin is the more active form of the protein and has a more relevant role in insulin sensitivity 
and in protecting against diabetes. Adiponectin is lower in men than women, possibly as a result of suppression by 
androgens .Moreover, women have higher proportions of high molecular weight adiponectin than men. ( Shimada et 
al.,2004; Kadowaki, et al.,2006 ; Heidemann et al.,2008). 
     Huerta,(2006) refer that insulin down-regulated adiponectin mRNA expression and it has been proposed that the 
hyperinsulinemia associated with insulin resistance in T2D may be responsible for the decrease in serum 
adiponectin. 
 
2. Materials and Method 
   About two milliliters was collected into EDTA containing tubes and used for genetic 
analysis.Genomic DNA was prepared from whole blood extraction with genaid kit and was 
quantified by Nanodrop .Terminal restriction fragment (TRF) lengths were measured using the 
Southern-blotting technique . Briefly, equal amounts of DNA (2 µg) were digested with 
restriction enzymes HinfI (20 U) and RsaI (20 U) (Roche) for 2 h at 37°C to liberate TRFs, which 
include both subtelomeric repetitive DNA and telomeric TTAGGG repeats. The TRFs that 
determines the telomere lengths were separated by electrophoresis on 0.8% agarose gel denatured 
with 0.5 M NaOH/1.5 M NaCl and neutralized for 30 min in 0.5 M Tris and 1.5 M NaCl. The 
DNA was transferred overnight to a nylon membrane positively charged using capillary transfer. 
The membranes were then hybridized with telomeric probe digoxigenin for 3 h in the 
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hybridization solution. Wash the blotting membrane 3 times with 2x SSC.The digoxigenin-
labelled probe was detected by the digoxigenin luminescent detection procedure and exposed on 
X-ray film( Jeanclos et al., 1998; Bentos et al., 2001; Bentos et al., 2004 ; Adaikalakoteswari et 
al., 2005) . 
 
3.Result: 
      Chemiluminescent detection of Terminal Restriction Fragment (TRFs) of genomic DNA from White Blood 
Cells (WBCs)of control and diabetic subjects,show in Figure(1),(2) and (3).Determinants of TRF length in the total 
samples measuring by base pairs (bp) shown in Table(1) and Table(2). 
Telomere length analysis in control and diabetic patients according to the gender : the study revealed that telomere 
length(TL) were differences between males and females of control group (Table 3). Age- adjusted telomere length 
were shorter in males than in females of control subjects (13,200 bp ) vs. (11,600 bp), (14,200 bp) vs. (13,000 bp) and 
(15,100 bp) vs. (13,800 bp) and this differences in TL between males and females decreased as aging increased, while 
this gender differences in TL was not observed among the diabetic patients as shown in Table(4). 
Telomere length analysis in control and diabetic patients according to the aging  :  among the controls and diabetic 
group, the telomere length were shorter in older subjects than younger for both males and females as shown in  
(Table 5) and (Table 6). 
Telomere length analysis between control  and diabetic patient:  the result show in Table (7) differences in TL 
between control and diabetic subjects. TL were shorter in the patients with Type 2diabetes compared with the control 
subjects ,and this differences in TL in first duration of male diabetic patients(2,100 bp) in male(55 years) and (1,900 
bp) in male (65 years) and in second duration of  female diabetic patients (3,600 bp) in female (55 years) and (2,900 
bp) in female (65 years) were shortest compared with other duration.. 
Telomere length analysis in diabetic patients according to the family history of disease :the differences in TL in 
patients with family history of disease  shown in Table (8).TL in patients with family history of disease were shorter 
than patients without family history of disease and this differences in TL in patients with family history of disease from 
mother were shortest than patients with family history of disease from father. 
 
4. Conclusion 
     Age- adjusted telomere length were shorter in males than in females of control subjects and this differences in TL 
between males and females decreased as aging increased (Table 3),this is because that estrogen may be linked to 
leukocyte telomere dynamics through its anti-inflammatory property it lowers the production of cytokines including 
the proinflammatory TNFα caused by oxidative stress, also antioxidant property of estrogen and ability of estrogen 
to stimulate telomerase a reverse transcriptase that elongates telomere ends(Aviv et al.,2006).  Hanna et al.,(2009) 
refer to the two mechanisms by which estrogen may positively regulate telomere length:(i)estrogen may ameliorate 
the negative effects of reactive oxygen species which reduce telomere length by inducing single strand breaks and(ii) 
estrogen may stimulate telomerase activity. Bekaert et al.,(2005) indicate to differences in telomere length between 
men and women and has been attributed to differences in hormonal status and lifestyle, linked to anti-oxidative 
defences, also body size differences and different telomere dynamics on the X and Y chromosomes have been 
proposed. This protection in telomere length by estrogen decreased with aging because the estrogen level decreased 
as aging progressed not only the drop in estrogen but also the redistribution of body fat centrally would alter 
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leukocyte telomere attrition because fat is the source of other adipocytokines that impact both inflammation and 
insulin resistance(Aviv et al.,2006).  While this gender differences in TL was not observed among the diabetic 
patients in which the TL of female were shorter than in males (Table 4),this may be because reduced adiponectin 
levels in diabetic patients than control and the mean of adiponectin levels lowest in female diabetic patients than 
male diabetic patients (Snijder et al.,2006). 
    AL-Attas et al.,(2010) refer to the significant positive association of adiponectin with TL suggested that 
adiponectin may be an anti-aging agent by way of improving insulin sensitivity, decreasing inflammation , cell 
oxidative function, and reversing endothelial dysfunction which is agreement with my study by the lowest of 
adiponectin levels in female diabetic patients made the TL did not differ from the male diabetic patients. This result 
agreement with study of Adaikalakoteswari et al.,(2005) that found the gender difference was absent in Type 2 
diabetic subjects and it is well known that women with Type 2 diabetes lose their protection from coronary artery 
disease. The difference average in TL between males and females of control group was (1,600 bp) in average age (45 
years) and decreased as aging increased become (1,200 bp) in average age (55 years) and (1,300 bp) in average age 
(65 years) (Table 3).In diabetic patients the difference average in TL between males and females (Table 4) was 
convergence in first duration of disease(1,100 bp and 1,700 bp) to control group in average age (55 and 65 
years),while in second duration the difference average of TL in females was shorter than males (1,500 bp and 1000 
bp )because the lowest of adiponectin levels in females diabetic patients, but this differences in TL decreased in third 
duration of disease (100 bp and 300 bp)because the levels of adiponectin increased with duration (Looker et 
al.,2004).    
  The telomere length were shorter in older subjects than younger for both groups  and for both males and females 
(Table 5 and Table 6) , this may because the telomere length of circulating leukocytes decreases with age (Risques et 
al.,2007). Telomeres progressively shorten with each cell division in cultured primary human cells, until a critically 
shortened length is achieved, upon which the cells enter replicative senescence , numerous reports suggest that 
telomere shortening may be associated with organismal aging, with concomitant metabolic decline and increased risk 
for disease and death ,several cross-sectional studies in humans have shown that telomere length in white blood cells 
is inversely related to the age of the cell donor (Atzmona et al.,2010). The difference average in TL was (2,200 bp 
and 1,900 bp between 65 and 45 years of male and female),(1,400 bp and 1,000 bp between 55 and 45 years of male 
and female) and (800 bp and 900 bp between 65 and 55 years of male and female ), this differences because the 
telomere attrition increased with aging, but this differences was less in females than males because the mechanical 
protection of females by estrogen .In diabetic patients the difference average in TL was shorter than control group for 
the same age and was shorter in females than males (100 bp in first duration vs.700 bp and 100 bp in second duration 
vs. 600 bp), this because that females contain high levels of HMW adiponectin than males which acted active form 
of this protein (Snijder et al.,2006) , so decreased levels of HMW adiponectin in females diabetic patients made her 
more exposed to the telomere attrition than males but in third duration the average differences in TL in females was 
less than males(500 bp vs. 300 bp in males) ,this because that the adiponectin increased with duration of disease 
(Looker et al.,2004). The results show in Table (7) differences in Telomere Length(TL) between control and diabetic 
subjects. TL were shorter in the patients with Type 2 diabetes compared with the control subjects , this may be due to 
insulin resistance and oxidative stress are associated with accelerated telomere attrition in leukocytes .Both of these 
factors are also implicated in the biology of aging and in aging-related disorders, including Type 2 diabetes. Cells are 
more likely to undergo apoptosis if exposed to increased oxidative insult (Makino et al.,2009). 
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    Higher glucose and insulin were associated with shorter telomeres and low telomerase activity , while good 
glycemic control was associated with more favorable telomere dynamics (Harville et al.,2010). 
     Epel,(2009) show the mechanism in which the glucose and insulin  causes the shorting of telomere, glucose and 
increased glycolysis can decrease sirtuins and autophagy. Sirtuins (protein deacetylases) are important for stabilizing 
DNA and for longevity. They appear to reduce inflammation and oxidative stress which promote stress resistance, 
and thus promote stability of the telomere. Autophagy(the breaking down and recycling of damaged molecules) is an 
important housekeeping function of the cell. It thus allows cells to adapt to their changing environment and might be 
thought of as a key player in allostasis of the cell. Autophagy,or ‘self-eating’, occurs by enzymatic degradation of 
intracellular ‘garbage".Autophagy becomes impaired with aging. Insulin may also regulate rate of autophagy, high 
levels of circulating insulin can impair autophagy in the kidney, whereas decreased insulin receptor signaling 
promotes autophagy. 
        Fernandez-Egea et al.,(2009) , Peng et al.,(2009) and Salpea et al., (2010) mentions that shortened telomere is 
associated with type 1 and type 2 diabetes ,because abnormal oxidation/reduction balance has also been associated 
with diabetes .Oxidative stress accelerates aging, increases the amount of telomeric DNA lost during each replication 
cycle. AL-Saadi,(2010) and You et al.,(2010) also refer that oxygen free radicals are a major cause of telomere 
shortening and that reduction in oxidative stress reduces the rate of telomere shortening. Elevated inflammatory 
activity could accelerate leukocyte telomere shortening by promoting cell turnover and replicative senescence, and 
by inducing the release of reactive oxygen species that damage telomeric DNA via oxidative stress(O’Donovan et 
al.,2011). The average of TL in first duration of male diabetic patients and second duration of  female diabetic 
patients were shorter compared with other duration, this may be because the adiponectin level was lowest and the 
levels of TG was highest in these durations compared with other duration . Adiponectin was decrease in the presence 
of impaired glucose regulation and early diabetes, whereas long diabetes duration is associated with a significant 
increase in circulating adiponectin, because the changes in insulin concentration with increasing duration of diabetes 
(Looker et al.,2004 ; Eynatten et al.,2009). 
   Al-Attas et al.,(2010) indicate to the significant positive association of adiponectin to TL suggests that adiponectin 
may be an anti-aging agent by way of improving insulin sensitivity, decreasing inflammation and cell oxidative 
function, and reversing endothelial dysfunction. Recent studies by Monickaraj et al.,(2012) refer to significant 
negative relationship between adiposity measure and telomere length and we measure telomere length in adipose 
tissue from both subcutaneous and visceral locations, and conclude for first time that adipose hypertrophy which 
connected with decrease of adiponectin secretion and higher levels of pro-inflammatory had shortened of telomere 
length. The results show that TL in patients with family history of disease were shorter than patients without family 
history of disease and TL from mother genetic origin was shorter than TL from father genetic origin (Table 8),  this 
is because the telomeres hold aunique advantage as amarker for biological aging and risk of disease development 
because they represent both an inherited predisposition to cell senescence as well as acumulative lifelong burden of 
oxidative stress and several studies have shown that telomere length is familial  (Mainous et al.,2010) . Nawrot et al., 
(2004) mention that the X chromosome harbours the DKC1gene encoding the protein dyskerin, which is important 
for stable accumulation of the hTR component of telomerase. Also nitric oxide activates telomerase , delays cell 
senescence ,react with cellular radicals and reduce oxidative stress resulting in telomerase activation. It is noteworthy 
that the gene encoding the angiotensin II type 2 receptor (AGTR2), stimulation of which leads to enhanced nitric 
oxide production also maps to the X chromosome . 
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Figure(1): Chemiluminescent detection of Terminal Restriction Fragment (TRFs) of genomic DNA from White 
Blood Cells (WBCs) .Lanes 1: molecular weight marker (0.8-21.2 Kb);Lanes 2: sample from male control (45 
years); Lanes 3: sample from male diabetic subject (45 years, duration of disease (1.5)years); Lanes 4:sample from 
male diabetic subject (45 years, duration of disease (11) years); Lanes 5: sample from female control (45 
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years);Lanes 6:sample from male diabetic subject (58 years, duration of disease (8) years, non genetic);Lanes 7: 
sample from male diabetic subject (58 years, duration of disease (8) years, genetic from father); Lanes 8: sample 
from female diabetic subject(58 years, duration of disease (8) years, genetic from mother); Lanes 9:sample from 
female diabetic subject (58 years,duration of disease (8) years, non genetic). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure(2): Chemiluminescent detection of  Terminal Restriction Fragment (TRFs) of genomic           
DNA from White Blood Cells (WBCs). Lanes 1: molecular weight marker (0.8-21.2 Kb);Lanes 2:                 
sample from male control (55 years); Lanes 3: sample from male diabetic subject (55 years, duration of disease (1) 
years); Lanes 4: sample from male diabetic subject  (55 years, duration of disease (6) years); Lanes 5:sample from 
male diabetic subject (55 years, duration of disease (11) years); Lanes 6: sample from female control (55  years); 
Lanes 7: sample from female diabetic subject (55 years, duration of disease (3) years); Lanes 8: sample from female 
diabetic subject  (55 years, duration of disease (7) years); Lanes 9: sample from female diabetic subject (55 years, 
duration of disease (11) years).   
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Figure(3): Chemiluminescent detection of Terminal  Restriction Fragment (TRFs) of genomic DNA from White 
Blood Cells (WBCs) .Lanes 1:   molecular weight marker (0.8-21.2 Kb);Lanes 2: sample from male control (65 
years); Lanes 3 :sample from male diabetic subject(65 years, duration of disease (2) years); Lanes 4: samplefrom 
male diabetic subject (65 years, duration of disease (10) years); Lanes 5: sample from male diabetic subject (65 
years, duration of disease (26) years); Lanes 6: sample from female control (65 years); Lanes 7: sample from female 
diabetic subject (65 years,  duration of disease (2) years); Lanes 8:  sample from female diabetic subject  (65 years, 
duration of disease (8) years); Lanes  9: sample from female diabetic subject(65 years, duration of disease (11) 
years). 
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Table(1):Average of Telomere length measured by base pairs (bp) in subjects with and without Type 2 diabetes (N0.= 
3)                       
TL(bp)  in 
control male 
(45 year) 
TL(bp)  in male diabetic patients (45 year)  TL(bp)  in 
control 
female 
(45 year) 
TL(bp)  in female diabetic patients (45 
year) 
0-5(1) >5-10 (2) >10(3) 0-5(1) >5-10 (2) >10(3) 
13,200  14,900  14,100   - 11,600   -  -  - 
TL(bp)  in 
control male 
(55 year) 
TL in male diabetic patients (55 year) TL(bp)  in 
control 
female 
(55 year) 
TL(bp)  in female diabetic patients (55 
year) 
0-5(1) >5-10 (2) >10(3) 0-5(1) >5-10 (2) >10(3)  
14,200  16,300 15,100  14,900 13,000 15,200  16,600  15,000  
TL(bp)  in 
control male 
  (65 year) 
TL (bp) in male diabetic patients (65 year) TL(bp)  in 
control 
female (65 
year) 
TL(bp)  in female diabetic patients (65 
year) 
0-5(1) >5-10 (2) >10(3) 0-5(1) >5-10 (2) >10(3)  
15,100  17,000  15,700  15,200  13,800  15,300  16,700  15,500  
TL:Telomere length (1):First duration of disease (2): Second duration of disease(3): Third duration of disease 
Table(2): Average of Telomere length measured by base pairs(bp)  in patients from genetic origin and patients from 
non-genetic origin (N0.= 3) 
TL (bp) in male from 
non-genetic origin (58 
year)(>5-10) 
TL (bp) in male from 
genetic origin (58 
year)(>5-10) 
TL(bp)  in female from 
non-genetic origin  (58 
year)(>5-10) 
TL(bp)  in female from 
genetic origin (58 
year)(>5-10) 
15,300  15,700  14,900  15,900  
TL :Telomere length 
Table(3): The difference average in Telomere length between males and females of control group. 
Male difference from Female 
1,600 bp male difference from female (45 year) 
1,200 bp male difference from female (55 year)  
1,300 bp male difference from female (65 year) 
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Table(4): The difference average in Telomere length between male and female of diabetic patients.  
First duration 
1,100bp male difference from female (0-5) (55 year) 
1,700bp male difference from female (0-5) (65 year) 
Second duration 
1,500bp female difference from male (5- >10) (55 year) 
1000bp female difference from male (5- >10) (65 year) 
Third duration 
100bp female difference from male (>10) (55 year) 
300bp female difference from male (>10) (65 year) 
 
Table(5): The difference average in Telomere length as aging increased for both males and females of control groups. 
                      
Control male Control female 
1,900bp (65 difference from 45) 2,200bp (65 difference from 45) 
1,000bp (55 difference from 45) 1,400bp(55 difference from 45) 
900bp (65 from difference 55) 800bp (65 difference  from 55) 
Table(6): The difference average in Telomere length of diabetic  patients as aging increased                        
Male Female 
700 (65 difference from 55) (0-5) 100 (65 difference from 55) (0-5) 
600 (65 difference from 55) (>5-10) 100 (65 difference from 55) (>5-10) 
300 (65 difference from 55) (>10) 500 (65 difference from 55) (>10) 
Table(7): The difference average in Telomere length between control and diabetic patients according to the duration of 
disease  
Male (45) Female (45) 
1,700bp (0-5) - 
- - 
900bp (>10) - 
Male (55) Female (55) 
2,100bp (0-5) 2,200bp (0-5) 
900bp (>5-10) 3,600bp (>5-10) 
700 (>10) 2,000 (>10) 
Male (65) Female (65) 
1,900bp (0-5) 1,500bp (0-5) 
600bp (>5-10) 2,900bp (>5-10) 
100 (>10) 1,700 (>10) 
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Table(8): The difference average in Telomere length between patients from genetic origin than patients from non-
genetic origin  
TL in male diabetic patients from father genetic 
origin 
TL in female diabetic patients from mother genetic origin 
400bp 1000bp 
TL :Telomere length. 
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